Injectable GLP-1s bypass the digestive system, so the dose can be smaller and absorption is more predictable
From topical research: Most commonly reported observation: mild transient redness at application site (attributed to vascular activity from VEGF stimulation) No systemic adverse events reported in human topical studies at standard concentrations No evidence of carcinogenicity or mutagenicity in available in vitro models From injectable research (preclinical): At supratherapeutic doses in animal models, mild injection site reactions have been noted No organ toxicity observed in standard preclinical safety panels No immunogenicity concerns identified (consistent with its endogenous structure) Copper considerations: GHK-Cu delivers a small amount of bioavailable copper
There is also a lot of useful information given on dosages and types of supplements and how they differ and which are best and the information is all well referenced
Semaglutide: Nausea, diarrhea, and constipation happen here, too, but people may handle it better if they start at a lower dose
The most common side effects are mild nausea, constipation, or diarrhea especially during the first few weeks
Ozempic is a prescription GLP-1 receptor agonist medication containing Semaglutide